C&E Chemical and Engineering News
Originally Posted: August 20, 2020
Robert Harrod, a virologist in the SMU Department of Biological Sciences, has studied oleandrin’s ability to block human T-cell leukemia virus, type 1, a retrovirus that causes fatal blood cancer, from spreading to other cells in test tubes.
“Even if (oleandrin) does make it into treatment of coronavirus as a therapeutic, this is going to have to be monitored very closely by doctors,” Harrod says. “It is a very dangerous compound.”